A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
11/2011
11/17/2011	WO2011140638A1 Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1
11/17/2011	WO2011140630A1 Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
11/17/2011	WO2011140627A1 Nucleic acid-containing lipid particles and related methods
11/17/2011	WO2011127405A9 Methods and compositions for enhanced delivery of compounds
11/17/2011	WO2011120156A8 Polyamine-containing polymers and methods of synthesis and use
11/17/2011	WO2011113855A3 Pharmaceutical composition for treatment of increased intraocular pressure
11/17/2011	WO2011090725A3 Gastroretentive solid oral dosage forms with swellable hydrophilic polymer
11/17/2011	WO2011090724A3 Gastroretentive solid oral dosage forms with lipid-based low-density excipient
11/17/2011	WO2011087804A3 Peptide- polynucleotide compositions for transfecting a cell with dna and for treating a neurodegenerative disease
11/17/2011	WO2011087629A3 Microcrystalline cellulose and calcium carbonate compositions useful as recompactible pharmaceutical excipients
11/17/2011	WO2011085209A3 Methods and compositions for applying moxifloxacin to the ear
11/17/2011	WO2011085013A3 Vitamin c composition for use in the prevention and treatment of stretch marks, radiation dermatitis, and other skin conditions and methods of using the same
11/17/2011	WO2011084620A3 Particles for multiple agent delivery
11/17/2011	WO2011084518A3 Therapeutic polymeric nanoparticles comprising corticosteroids and methods of making and using same
11/17/2011	WO2011079260A3 Stabilized virus like particles having enhanced mucosal immunogenicity
11/17/2011	WO2011076807A3 Lipids, lipid compositions, and methods of using them
11/17/2011	WO2011074006A3 Vaccine composition
11/17/2011	WO2011072290A3 Targeted dendrimer-drug conjugates
11/17/2011	WO2011072069A3 Gastric retentive pharmaceutical compositions for extended release of polypeptides
11/17/2011	WO2011071970A3 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt)
11/17/2011	WO2011068774A3 Methods for regulating gelation of hydrogel solutions and uses thereof
11/17/2011	WO2011059325A3 Dextran-hyaluronic acid based hydrogels
11/17/2011	WO2011038278A3 Micelle encapsulation of therapeutic agents
11/17/2011	WO2011026641A9 Disulfide-linked polyethyleneglycol/peptide conjugates for the transfection of nucleic acids
11/17/2011	US20110281914 Fentanyl composition for nasal administration
11/17/2011	US20110281912 Oral dispersible tablet
11/17/2011	US20110281810 Composition
11/17/2011	US20110281809 Methods and compositions for rapid treatment of otitis externa
11/17/2011	US20110281732 Crosslinked Polyvinylpyrrolidone Compositions
11/17/2011	US20110281292 Compositions and methods for identifying antigens which elicit an immune response
11/17/2011	US20110281021 Rapidly disintegrating dosage form for releasing active ingredients in the oral cavity or in body cavities
11/17/2011	US20110280949 Microparticles for use in immunogenic compositions
11/17/2011	US20110280944 Fibrous microcapsules and methods of assembly and use thereof
11/17/2011	US20110280937 Hard capsule
11/17/2011	US20110280922 Devices and methods for treating and/or preventing diseases
11/17/2011	US20110280914 Hydrogels crosslinked with gold nanoparticles and methods of making and using thereof
11/17/2011	US20110280908 Multimeric protein toxins to target cells having multiple identifying characteristics
11/17/2011	US20110280897 Polypeptides and uses thereof
11/17/2011	US20110280830 Albumin Fusion Proteins
11/17/2011	US20110280824 Furanone Copolymers
11/17/2011	US20110277339 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
11/17/2011	DE102010023850A1 New nanoparticles comprising a core, a protective shell that covers the core, and heme- and hemin molecules covalently bonded to the protective shell or the core, useful as dietary supplement and for treating iron deficiency and cancer
11/17/2011	CA2833415A1 Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1
11/17/2011	CA2816925A1 Nucleic acid-containing lipid particles and related methods
11/17/2011	CA2800497A1 Ratiometric combinatorial drug delivery
11/17/2011	CA2799468A1 Functional, cross-linked nanostructures for tandem optical imaging and therapy
11/17/2011	CA2799197A1 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-beta-trna synthetases
11/17/2011	CA2799169A1 Chlorotoxin variants, conjugates, and methods for their use
11/17/2011	CA2799091A1 Novel cationic lipids and methods of use thereof
11/17/2011	CA2799046A1 Il-1 binding proteins
11/17/2011	CA2798924A1 Improved methods for preparing squalene
11/17/2011	CA2798888A1 High concentration antibody formulations
11/16/2011	EP2386640A2 Delivering functional nucleic acids to mammalian cells via bacterially-derived, intact minicells
11/16/2011	EP2386576A1 Tumor-specific recognition molecules
11/16/2011	EP2386575A2 Dual specificity antibodies and methods of making and using
11/16/2011	EP2386565A2 Compounds and methods to inhibit or augment an inflammatory response
11/16/2011	EP2386313A1 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine
11/16/2011	EP2386297A1 Indigestible polymer: starch acetate -based film coatings for colon targeting
11/16/2011	EP2386291A1 Vaginally administrable progesterone-containing tablets and method for preparing same
11/16/2011	EP2386290A2 Modulating drug release rate by controlling the kinetics of the pH transition in hydrogels
11/16/2011	EP2386289A1 Clay compositions
11/16/2011	EP2385844A2 Complex comprising both heparin binding proteins and heparin-hydroxyalkyl starch conjugates
11/16/2011	EP2385826A2 Methods and materials for delivering bile acids
11/16/2011	EP2385825A1 Factor viii formulations
11/16/2011	EP2385824A2 Nanoparticle pharmaceutical formulations
11/16/2011	EP2385822A1 Pharmaceutical composition containing malathion and a volatile cyclic silicone
11/16/2011	EP2142170B1 A method of producing fast dissolving tablets
11/16/2011	EP2003130B1 Novel pyridine derivative having anti-helicobacter pylori activity
11/16/2011	EP1978973B1 Use hedgehog kinase antagonists to inhibit hedgehog signaling and to treat cancer
11/16/2011	EP1874729B1 Biodegradable polyphosphazenes containing pyrrolidone side groups
11/16/2011	EP1867673B1 Coordination compound composed of diaminocyclohexane platinum (ii) and block copolymer and anti-cancer agent comprising the same
11/16/2011	EP1699491B1 Branched polyethylene glycol for linking polymer residues to antibodies
11/16/2011	EP1633368B1 Foamable pharmaceutical compositions and methods for treating a disorder
11/16/2011	EP1549327B1 Composition for treating hemorrhoids
11/16/2011	EP1534340B1 Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto
11/16/2011	EP1458646B1 Process for preparation of precipitated silica having a low uptake water
11/16/2011	EP1455588B1 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis
11/16/2011	EP1392364B1 Liquid polymer composition for prevention and treatment of the oral cavity diseases
11/16/2011	EP1357928B1 A novel pharmaceutical compound and methods of making and using same
11/16/2011	CN1929865B Conjugates of hydroxyalkyl starch and a protein
11/16/2011	CN1863921B Methods for expression and purification of immunotoxins
11/16/2011	CN102245642A Conjugates of GLP-1 agonists and uses thereof
11/16/2011	CN102245636A Etoposide and doxorubicin conjugates for drug delivery
11/16/2011	CN102245559A Aminoalcohol lipidoids and uses thereof
11/16/2011	CN102245214A Biodegradable polymer - bioactive moiety conjugates
11/16/2011	CN102245213A Modifications of nucleic acid vectors with polymers comprising charged quaternary amino groups
11/16/2011	CN102245212A Thermosensitive composition preventing tissue adhesion and preparation method thereof
11/16/2011	CN102245211A Combined drug administration
11/16/2011	CN102245210A Octreotide depot formulation with constantly high exposure levels
11/16/2011	CN102245209A Formulation for the buccal transmucosal administration of setrons
11/16/2011	CN102245171A Slow-release particle and a production method therefor
11/16/2011	CN102245168A Nanoparticle compositions
11/16/2011	CN102245167A Formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules
11/16/2011	CN102241837A Thiolated-chitosan-based temperature-sensitive in-situ hydrogel as well as preparation method and uses thereof
11/16/2011	CN102241825A Preparation method of supermolecular polymer micelle
11/16/2011	CN102241790A Amphipathic chitosan derivative and preparation method and application thereof
11/16/2011	CN102241742A Peptides and compounds that bind to a thrombopoietin receptor
11/16/2011	CN102240406A Method for realizing surface modification of tumor targeted nonviral vector and application thereof
11/16/2011	CN102240403A Method for preparing CaCO3 nanotube/podophyllum composite material
11/16/2011	CN102240385A Traditional Chinese medicine dripping pill for treating woman postpartum disease and preparation method thereof

1 ... 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 ... 1712